blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2028270

EP2028270 - Modified recombinant vaccinia viruses, uses thereof [Right-click to bookmark this link]
Former [2009/09]Modified recombinant vaccina viruses and uses thereof
[2009/10]
StatusNo opposition filed within time limit
Status updated on  21.12.2012
Database last updated on 20.05.2024
Most recent event   Tooltip18.07.2014Lapse of the patent in a contracting state
New state(s): HU		published on 20.08.2014  [2014/34]
Applicant(s)For all designated states
Genelux Corporation
3030 Bunker Hill Street Suite 310
San Diego, California 92109 / US
[2011/33]
Former [2009/09]For all designated states
Genelux Corporation
3030 Bunker Hill Steet, Suite 310
San Diego, California 92109 / US
Inventor(s)01 / Szalay, Aladar
7740 North Fork Road
Highland, CA 92346 / US
02 / Timiryasova, Tatyana
130 Scotrun Drive
Scotrun, PA 18355 / US
03 / Yu, Yong A.
3830 Elijah Court
Unit 422
San Diego, CA 92130 / US
04 / Zhang, Qian
12601 El Carmino Road
San Diego, CA 92130 / US
 [2012/07]
Former [2009/09]01 / Szalay, Aladar
7740 North Fork Road
Highland, CA 92346 / US
02 / Timiryasova, Tatyana
130 Scotrun Drive
Scotrun, PA 18355 / US
03 / Yu, Yong A.
3830 Elijah Court Unit 422
San Diego, CA 92130 / US
04 / Zhang, Qian
12601 El Carmino Road
San Diego, CA 92130 / US
Representative(s)Blance, Stephen John
Boult Wade Tennant
Verulam Gardens
70 Gray's Inn Road
London WC1X 8BT / GB
[N/P]
Former [2012/07]Blance, Stephen John
Boult Wade Tennant Verulam Gardens 70 Gray's Inn Road
London WC1X 8BT / GB
Former [2009/09]Blance, Stephen John
Boult Wade Tennant Verulam Gardens 70 Gray's Inn Road
London WC1X 8BT / GB
Application number, filing date08019998.718.06.2004
[2009/09]
Priority number, dateEP2003001382618.06.2003         Original published format: EP 03013826
EP2003001847814.08.2003         Original published format: EP 03018478
EP2003002428322.10.2003         Original published format: EP 03024283
[2009/09]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2028270
Date:25.02.2009
Language:EN
[2009/09]
Type: A3 Search report 
No.:EP2028270
Date:20.05.2009
[2009/21]
Type: B1 Patent specification 
No.:EP2028270
Date:15.02.2012
Language:EN
[2012/07]
Type: B9 Corrected patent specification 
No.:EP2028270
Date:25.04.2012
[2012/17]
Search report(s)(Supplementary) European search report - dispatched on:EP21.04.2009
ClassificationIPC:C12N7/04, A61K35/76, C12N15/863, A61K35/74, C12Q1/02
[2009/09]
CPC:
A61K35/74 (EP,US); A61K39/285 (US); A61K35/744 (EP,US);
A61K35/768 (EP,US); A61K45/06 (US); A61K9/0019 (US);
A61P29/00 (EP); A61P35/00 (EP); A61P35/04 (EP);
A61P37/00 (EP); A61P37/02 (EP); A61P37/04 (EP);
A61P43/00 (EP); C07K16/30 (EP,US); C07K16/40 (EP,US);
C12N15/86 (EP,US); C12N7/00 (EP,US); C12P19/34 (EP,US);
C12P21/02 (EP,US); A61K2039/5254 (US); A61K2039/5256 (EP,US);
A61K39/00 (EP,US); A61K48/00 (EP,US); C12N2710/24132 (EP,US);
C12N2710/24134 (US); C12N2710/24143 (EP,US); C12N2710/24161 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/09]
Extension statesAL17.11.2008
HR17.11.2008
LT17.11.2008
LV17.11.2008
MK17.11.2008
TitleGerman:Modifizierte, rekombinante Vacciniaviren und deren Verwendungen[2011/24]
English:Modified recombinant vaccinia viruses, uses thereof[2011/24]
French:Virus de vaccinia recombinés modifiés et utilisations associées[2011/24]
Former [2009/09]Modifizierte, rekombinante Impfstoffviren und deren Verwendungen
Former [2009/09]Modified recombinant vaccina viruses and uses thereof
Former [2009/09]Virus de vaccin recombiné modifié et utilisations associées
Examination procedure17.11.2008Examination requested  [2009/09]
04.11.2009Amendment by applicant (claims and/or description)
01.10.2010Despatch of a communication from the examining division (Time limit: M04)
27.01.2011Reply to a communication from the examining division
25.07.2011Communication of intention to grant the patent
25.11.2011Fee for grant paid
25.11.2011Fee for publishing/printing paid
Parent application(s)   TooltipEP04816752.2  / EP1644492
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20040816752) is  04.06.2007
Opposition(s)16.11.2012No opposition filed within time limit [2013/04]
Fees paidRenewal fee
17.11.2008Renewal fee patent year 03
17.11.2008Renewal fee patent year 04
17.11.2008Renewal fee patent year 05
23.06.2009Renewal fee patent year 06
23.06.2010Renewal fee patent year 07
24.06.2011Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU18.06.2004
AT15.02.2012
BE15.02.2012
CY15.02.2012
CZ15.02.2012
DK15.02.2012
EE15.02.2012
FI15.02.2012
NL15.02.2012
PL15.02.2012
RO15.02.2012
SE15.02.2012
SI15.02.2012
SK15.02.2012
TR15.02.2012
BG15.05.2012
GR16.05.2012
ES26.05.2012
PT15.06.2012
IE18.06.2012
LU18.06.2012
CH30.06.2012
LI30.06.2012
MC30.06.2012
[2014/34]
Former [2014/27]AT15.02.2012
BE15.02.2012
CY15.02.2012
CZ15.02.2012
DK15.02.2012
EE15.02.2012
FI15.02.2012
NL15.02.2012
PL15.02.2012
RO15.02.2012
SE15.02.2012
SI15.02.2012
SK15.02.2012
TR15.02.2012
BG15.05.2012
GR16.05.2012
ES26.05.2012
PT15.06.2012
IE18.06.2012
LU18.06.2012
CH30.06.2012
LI30.06.2012
MC30.06.2012
Former [2014/21]AT15.02.2012
BE15.02.2012
CY15.02.2012
CZ15.02.2012
DK15.02.2012
EE15.02.2012
FI15.02.2012
NL15.02.2012
PL15.02.2012
RO15.02.2012
SE15.02.2012
SI15.02.2012
SK15.02.2012
TR15.02.2012
BG15.05.2012
GR16.05.2012
ES26.05.2012
PT15.06.2012
IE18.06.2012
CH30.06.2012
LI30.06.2012
MC30.06.2012
Former [2013/46]AT15.02.2012
BE15.02.2012
CY15.02.2012
CZ15.02.2012
DK15.02.2012
EE15.02.2012
FI15.02.2012
NL15.02.2012
PL15.02.2012
RO15.02.2012
SE15.02.2012
SI15.02.2012
SK15.02.2012
BG15.05.2012
GR16.05.2012
ES26.05.2012
PT15.06.2012
IE18.06.2012
CH30.06.2012
LI30.06.2012
MC30.06.2012
Former [2013/33]AT15.02.2012
BE15.02.2012
CY15.02.2012
CZ15.02.2012
DK15.02.2012
EE15.02.2012
FI15.02.2012
NL15.02.2012
PL15.02.2012
RO15.02.2012
SE15.02.2012
SI15.02.2012
SK15.02.2012
BG15.05.2012
GR16.05.2012
PT15.06.2012
IE18.06.2012
CH30.06.2012
LI30.06.2012
MC30.06.2012
Former [2013/20]AT15.02.2012
BE15.02.2012
CY15.02.2012
CZ15.02.2012
DK15.02.2012
EE15.02.2012
FI15.02.2012
NL15.02.2012
PL15.02.2012
RO15.02.2012
SE15.02.2012
SI15.02.2012
SK15.02.2012
GR16.05.2012
PT15.06.2012
IE18.06.2012
CH30.06.2012
LI30.06.2012
MC30.06.2012
Former [2013/08]AT15.02.2012
BE15.02.2012
CY15.02.2012
CZ15.02.2012
DK15.02.2012
EE15.02.2012
FI15.02.2012
NL15.02.2012
PL15.02.2012
RO15.02.2012
SE15.02.2012
SI15.02.2012
SK15.02.2012
GR16.05.2012
PT15.06.2012
MC30.06.2012
Former [2013/07]AT15.02.2012
BE15.02.2012
CY15.02.2012
CZ15.02.2012
DK15.02.2012
EE15.02.2012
FI15.02.2012
NL15.02.2012
PL15.02.2012
RO15.02.2012
SE15.02.2012
SI15.02.2012
SK15.02.2012
GR16.05.2012
PT15.06.2012
Former [2012/50]BE15.02.2012
CY15.02.2012
CZ15.02.2012
DK15.02.2012
EE15.02.2012
FI15.02.2012
NL15.02.2012
PL15.02.2012
RO15.02.2012
SE15.02.2012
SI15.02.2012
SK15.02.2012
GR16.05.2012
PT15.06.2012
Former [2012/49]BE15.02.2012
CY15.02.2012
CZ15.02.2012
DK15.02.2012
EE15.02.2012
FI15.02.2012
NL15.02.2012
PL15.02.2012
RO15.02.2012
SE15.02.2012
SI15.02.2012
GR16.05.2012
PT15.06.2012
Former [2012/48]BE15.02.2012
CY15.02.2012
EE15.02.2012
FI15.02.2012
NL15.02.2012
PL15.02.2012
SE15.02.2012
GR16.05.2012
PT15.06.2012
Former [2012/41]BE15.02.2012
CY15.02.2012
FI15.02.2012
NL15.02.2012
PL15.02.2012
GR16.05.2012
PT15.06.2012
Former [2012/37]BE15.02.2012
FI15.02.2012
NL15.02.2012
PL15.02.2012
GR16.05.2012
PT15.06.2012
Former [2012/36]NL15.02.2012
GR16.05.2012
Former [2012/35]NL15.02.2012
Documents cited:Search[A]  - GNANT M F ET AL, "Systemic administration of a recombinant vaccinia virus expressing the cytosine deaminase gene and subsequent treatment with 5-fluorocytosine leads to tumor-specific gene expression and prolongation of survival in mice", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD.; US, (19990715), vol. 59, no. 14, pages 3396 - 3403, XP009106317 [A] * page 3397, last paragraph - page 3398, first paragraph; page 3398, last two paragraphs - page 3399, bottom of left hand column; page 3400, figure 4 * * page 3398, second paragraph of 'Results' - right hand column, paragraph 3; page 3399, table 1 *
 [A]  - MCCART J ANDREA ET AL, "Systemic cancer therapy with a tumor-selective vaccinia virus mutant lacking thymidine kinase and vaccinia growth factor genes", CANCER RESEARCH, (20011215), vol. 61, no. 24, ISSN 0008-5472, pages 8751 - 8757, XP002331814 [A] * page 8751 * * abstract *
 [DA]  - TIMIRYASOVA TATYANA M ET AL, "Construction of recombinant vaccinia viruses using PUV-inactivated virus as a helper", BIOTECHNIQUES, (200109), vol. 31, no. 3, ISSN 0736-6205, pages 534 - 540, XP008022947 [DA] * the whole document *
 [DA]  - TIMIRYASOVA ET AL, "VISUALIZATION OF VACCINIA VIRUS INFECTION USING THE RENILLA-LUCIFERASE-GFP FUSION PROTEIN", PROCEEDINGS OF THE 11TH INTERNATIONAL SYMPOSIUM ON BIOLUMINESCENCE AND CHEMILUMINESCENCE, (2000), pages 457 - 460, XP008023166 [DA] * page 457, paragraph 2 * * page 457, paragraph 4 - page 458, paragraph 1 *
Examination   - J. NUCL. MEDICINE, (1993), vol. 34, no. 7, pages 1140 - 1146
    - J. BIOL. CHEM., (1999), vol. 274, no. 49, pages 34838 - 34845
by applicantUS5693533
 US5718902
 WO9932646
 US5976796
    - MCCART ET AL., CANCER RES, (2001), vol. L, pages 8751 - 8757
    - KIM ET AL., SURGICAL PNCOL, (2001), vol. 10, pages 53 - 59
    - CARILLO, SIAM J APPLIED MATH, (1988), vol. 48, page 1073
    - PEARSON ET AL., PROC. NATL. ACAD. SCI. USA, (1988), vol. 85, page 2444
    - DEVEREUX, J. ET AL., NUCLEIC ACIDS RESEARCH, (1984), vol. 2, no. I, page 387
    - ATSCHUL, S.F. ET AL., J MOLEC BIOL, (1990), vol. 215, page 403
    - CARILLO ET AL., SIAM J APPLIED MATH, (1988), vol. 48, page 1073
    - NEEDLEMAN ET AL., J. MOL. BIOL., (1970), vol. 48, page 443
    - SMITH; WATERMAN, ADV. APPL. MATH., (1981), vol. 2, page 482
    - GRIBSKOV ET AL., NUCL. ACIDS RES., (1986), vol. 14, page 6745
    - ATLAS OF PROTEIN SEQUENCE AND STRUCTURE, NATIONAL BIOMEDICAL RESEARCH FOUNDATION, (1979), pages 353 - 358
    - WATSON ET AL., Molecular Biology of the Gene, THE BENJAMIN/CUMMINGS PUB. CO., (1987), page 224
    - KOZAK, J. BIOL. CHEM., (1991), vol. 266, pages 19867 - 19870
    - NOGRADY, Medicinal Chemistry A Biochemical Approach, OXFORD UNIVERSITY PRESS, (1985), pages 388 - 392
    - MURPHY ET AL., VIRUS RES., (1994), vol. 32, pages 13 - 26
    - ESCHER, PNAS, (1989), vol. 86, pages 6528 - 6532
    - CONTAG ET AL., MOL. MICROBIOL., (1995), vol. 18, pages 593 - 603
    - WU ET AL., PNAS USA, (2002), vol. 97, pages 8495 - 8500
    - LEWIS, J. MED. CHEM., (1999), vol. 42, pages 1341 - 1347
    - ADONAI ET AL., PNAS USA, (2002), vol. 99, pages 3030 - 3035
    - LEENDERS ET AL., J. NEURAL.TRANSM.SUPPL., (1994), vol. 43, pages 123 - 132
    - CALONDER ET AL., J. NEUROCHEM., (1999), vol. 73, pages 2047 - 2055
    - BESHARA ET AL., BR. J. HAEMATOL., (1999), vol. 104, pages 288 - 295
    - MOSS, CURR. OPIN. GENET. DEV., (1993), vol. 3, pages 86 - 90
    - BRODER; EARL, MOL. BIOTECHNOL., (1999), vol. 13, pages 223 - 245
    - TIMIRYASOVA ET AL., BIOTECHNIQUES, (2001), vol. 31, pages 534 - 540
    - GOEBEL ET AL., VIROLOGY, (1990), vol. 179, pages 247 - 266
    - VEIJOLA ET AL., J. BIOL. CHEM., (1994), vol. 269, pages 26746 - 26753
    - BLAKEMORE, ANNU. REV. MICROBIOL., (1982), vol. 36, pages 217 - 238
    - YANGET, ENZYME MICROB. TECHNOL., (2001), vol. 29, pages 13 - 19
    - ZIMMERMANN ET AL., NEURON, (1994), vol. 12, pages 11 - 24
    - VIDAL ET AL., EMBO J., (1990), vol. 9, pages 833 - 840
    - MAYFORD ET AL., CELL, (1995), vol. 81, pages 891 - 904
    - PINKERT ET AL., GENES & DEV., (1987), vol. 1, pages 268 - 76
    - MIKRYUKOV ET AL., BIOTEKHNOLOGYA, (1998), vol. 4, pages 442 - 449
    - ANTOINE ET AL., VIROLOGY, (1998), vol. 244, pages 365 - 396
    - MAYR ET AL., ZENTBL. BAKTERIOL. HYG. ABT 1 ORIG. B, (1978), vol. 167, pages 375 - 390
    - ANDO; MATUMOTO, JPN. J. MICROBIAL., (1979), vol. 14, pages 181 - 186
    - SUGIMOTO ET AL., MICROBIAL. IMMUOL., (1985), vol. 29, pages 421 - 428
    - TAKAHASHI-NISHIMAKI ET AL., J. GEN. VIROL., (1987), vol. 68, pages 2705 - 2710
    - EARL ET AL., SCIENCE, (1986), vol. 234, pages 728 - 831
    - LATHE ET AL., NATURE (LONDON, (1987), vol. 326, pages 878 - 880
    - BERNARDS ET AL., PROC. NATL. ACAD. SCI. USA, (1987), vol. 84, pages 6854 - 6858
    - ESTIN ET AL., PROC. NATL. ACAD. SCI. USA, (1988), vol. 85, pages 1052 - 1056
    - KANTOR ET AL., J. NATL. CANCER INST., (1992), vol. 84, pages 1084 - 1091
    - ROTH ET AL., PROC. NATL. ACAD. SCI. USA, (1996), vol. 93, pages 4781 - 4786
    - RAO ET AL., J. IMMUNOL., (1996), vol. 156, pages 3357 - 3365
    - CHAMBERLAIN ET AL., CANCER RES., (1996), vol. 56, pages 2832 - 2836
    - OERTLI ET AL., J. GEN. VIROL., (1996), vol. 77, pages 3121 - 3125
    - QIN; CHATTERJEE, HUMAN GENE THER., (1996), vol. 7, pages 1853 - 1860
    - MCANENY ET AL., ANN. SURG. ONCOL., (1996), vol. 3, pages 495 - 500
    - YU ET AL., MOL GENET GENOMICS, (2002), vol. 268, pages 169 - 178
    - CHAKRABARTI ET AL., BIOTECHNIQUES, (1997), vol. 23, pages 1094 - 1097
    - Current Protocols in Molecular Biology, GREEN PUBLISHING AND WILEY-INTERSCIENCE, (1992), vol. 15, page 16.17.2
    - BENES ET AL., GENE, (1993), vol. 130, page 151
    - Current Protocols in Molecular Biology, GREEN PUBLISHING AND WILEY-INTERSCIENCE, (1992), vol. 15, page 16172
    - TSUNG, J. VIROL., (1996), vol. 70, pages 165 - 171
    - TIMIRYASOVA ET AL., J. GENE 3 MED., (2001), vol. 3, pages 468 - 477
    - WANG ET AL., BIOLUMINESCENCE CHEMILUMINESCENCE, (1996), vol. 9, pages 419 - 422
    - WANG ET AL., MOL. GENET. GENOMICS, (2002), vol. 268
    - WANG ET AL., Bioluminescence and Chemiluminescence, WILEY, (1997), pages 419 - 422
    - WANG ET AL., MOL. GENET. GENOMICS, (2002), vol. 268, pages 160 - 168
    - CHAKRABARTI ET AL., MOL. CELL BIOL., (1985), vol. 5, pages 3403 - 3409
    - FLEXNER ET AL., NATURE, (1988), vol. 355, pages 259 - 262
    - FLEXNER ET AL., VIROLOGY, (1988), vol. 166, pages 339 - 349
    - VOISEY ET AL., BIOLECHNIQUES, (1998), vol. 24, pages 56 - 58
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.